NAT8 Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-87882
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Format
BSA Free
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the N-terminal region of human NAT8. Peptide sequence: KYQESDRQWVVGLLSRGMAEHAPATFRQLLKLPRTLILLLGGPLALLLVS The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Description
Novus Biologicals Rabbit NAT8 Antibody - BSA Free (NBP2-87882) is a polyclonal antibody validated for use in WB. All Novus Biologicals antibodies are covered by our 100% guarantee.
Scientific Data Images for NAT8 Antibody - BSA Free
Western Blot: NAT8 Antibody [NBP2-87882]
Western Blot: NAT8 Antibody [NBP2-87882] - Host: Rabbit. Target Name: NAT8. Sample Tissue: Human Hela Whole Cell. Antibody Dilution: 1.0ug/mlApplications for NAT8 Antibody - BSA Free
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Format
BSA Free
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: NAT8
Alternate Names
Camello-like protein 1, CML1, EC 2.3.1, EC 2.3.1.-, GLAkidney- and liver-specific gene product, Hcml1, N-acetyltransferase 8, N-acetyltransferase 8 (GCN5-related, putative), probable N-acetyltransferase 8, TSC501N-acetyltransferase 8 (camello like), TSC510
Gene Symbol
NAT8
Additional NAT8 Products
Product Specific Notices for NAT8 Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...